Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The DYRK Family of Kinases in Cancer: Molecular Functions and Therapeutic Opportunities
Jacopo Boni, Carlota Rubio-Pérez, Núria López-Bigas, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2106-2106
Open Access | Times Cited: 74

Showing 51-75 of 74 citing articles:

DYRK3 phosphorylates SNAPIN to regulate axonal retrograde transport and neurotransmitter release
Ye Hyung Lee, Bo Kyoung Suh, Unghwi Lee, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 6
Discovery of Potent, Selective, and Orally Bioavailable DYRK2 Inhibitors for the Treatment of Prostate Cancer
Kai Yuan, Fei Xia, Qiannan Li, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 16235-16256
Closed Access | Times Cited: 3
PAICS/DYRK3 Multienzyme Interactions as Coregulators of Purinosome Formation and Metabolism on Radioresistance in Oral Squamous Cell Carcinoma
Chin-Sheng Huang, Ming‐Shou Hsieh, Vijesh Kumar Yadav, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17346-17346
Open Access | Times Cited: 3
In silicomodeling studies ofN9-substituted harmine derivatives as potential anticancer agents: combination of ligand-based and structure-based approaches
Taoufik Akabli, Hamid Toufik, Fatima Lamchouri
Journal of Biomolecular Structure and Dynamics (2020) Vol. 40, Iss. 9, pp. 3965-3978
Closed Access | Times Cited: 6
Identification of cancer risk assessment signature in patients with chronic obstructive pulmonary disease and exploration of the potential key genes
Qingzhou Guan, Peng Zhao, Yange Tian, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 2308-2319
Open Access | Times Cited: 4
The Conserved Transcriptional Activation Activity Identified in Dual-Specificity Tyrosine-(Y)-Phosphorylation-Regulated Kinase 1
Xiuke Ouyang, Zhuqing Wang, Bingtong Wu, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 283-283
Open Access | Times Cited: 2
Hypomethylation of DYRK4 in peripheral blood is associated with increased lung cancer risk
Rong Qiao, Qiang Zhu, Feifei Di, et al.
Molecular Carcinogenesis (2023) Vol. 62, Iss. 11, pp. 1745-1754
Closed Access | Times Cited: 2
Anti-Proliferative Potential of Cynaroside and Orientin—In Silico (DYRK2) and In Vitro (U87 and Caco-2) Studies
Lucia Pîrvu, Lucia Pintilie, Adrian Albulescu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16555-16555
Open Access | Times Cited: 2
Anticancer drugs acting on signaling pathways, part 1: Tyrosine kinase inhibitors
Carmen Avendaño, J. Carlos Menéndez
Elsevier eBooks (2023), pp. 493-563
Closed Access | Times Cited: 1
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 3 Expression and Its Correlation with Prognosis and Growth of Serous Ovarian Cancer: Correlation of DYRK3 with Ovarian Cancer Survival
Jia Sun, Yingzi Zhang, Aijie Li, et al.
International Journal of Genomics (2024) Vol. 2024, pp. 1-13
Open Access
Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs
Amina Jamal Laham, Raafat El‐Awady, Maha Saber-Ayad, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access
Targeting CBP and p300: Emerging Anticancer Agents
Domiziana Masci, Michela Puxeddu, Romano Silvestri, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4524-4524
Open Access
Differential regulation of expression of the protein kinases DYRK1A and DYRK1B in cancer cells
Vincent Andreas Vorwerk, Gerrit Wilms, Aaron Babendreyer, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
CRISPR/Cas9-Mediated Knockout of DYRK1B in Triple Negative Breast Cancer Cells: Implications for Cell Proliferation, Apoptosis, and Therapeutic Sensitivity
Asrin Rashidi, Ernst‐Martin Füchtbauer, Zakaria Vahabzadeh, et al.
Biochemical Engineering Journal (2024), pp. 109553-109553
Closed Access
Elevated expression levels of the protein kinase DYRK1B induce mesenchymal features in A549 lung cancer cells
Soraya Sester, Gerrit Wilms, Joana Ahlburg, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
MaPom1, a Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase, Positively Regulates Thermal and UV-B Tolerance in Metarhizium acridum
Yu Zhang, Lei Song, Yuxian Xia
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11860-11860
Open Access
Intracellular Organization of Proteins and Nucleic Acids via Biomolecular Condensates in Human Health and Diseases
Raffaella Gallo
BioChem (2023) Vol. 3, Iss. 1, pp. 31-46
Open Access
WITHDRAWN: DYRK1A-mediated PLK2 phosphorylation regulates proliferation and invasion of glioblastoma cell
Shichuan Tan, Juan Zhao, Pin Wang
Research Square (Research Square) (2023)
Open Access
WITHDRAWN: DYRK1A-mediated PLK2 phosphorylation regulates proliferation and invasion of glioblastoma cell

Research Square (Research Square) (2023)
Open Access
Cellular selectivity and kinetics of clinical kinase inhibitors
Lena M. Berger
(2023)
Open Access
Non-canonical Kinases and Substrates in Cancer Progression
Francisco M. De La Vega
MDPI eBooks (2022)
Open Access
The DYRK1A protein kinase regulates ribosome mass and translation rates through transcriptional control of ribosomal protein genes expression
Di Vona, Barba, Ferrari, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Non-Canonical Kinases and Substrates in Cancer Progression
Francisco M. De La Vega
Cancers (2021) Vol. 13, Iss. 7, pp. 1628-1628
Open Access
Loss of the DYRK1A protein kinase results in reduction of ribosomal protein genes expression, ribosome mass and translation defects
Chiara Di Vona, Laura Barba, Roberto Ferrari, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Previous Page - Page 3

Scroll to top